Shopping Cart
Remove All
Your shopping cart is currently empty
OPC-14523 hydrochloride is an orally active sigma and 5-HT1A receptor agonist with antidepressant-like activity, showing high affinity for the sigma receptor σ1/2 (IC50=47/56 nM), the 5-HT1A receptor (IC50=2.3 nM), and the 5-HT transporter (IC50=80 nM).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $970 | 6-8 weeks | 6-8 weeks | |
| 10 mg | $1,289 | 6-8 weeks | 6-8 weeks | |
| 25 mg | $1,619 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks | |
| 1 mL x 10 mM (in DMSO) | $1,028 | 6-8 weeks | 6-8 weeks |
| Description | OPC-14523 hydrochloride is an orally active sigma and 5-HT1A receptor agonist with antidepressant-like activity, showing high affinity for the sigma receptor σ1/2 (IC50=47/56 nM), the 5-HT1A receptor (IC50=2.3 nM), and the 5-HT transporter (IC50=80 nM). |
| Targets&IC50 | [3H]-5-HT:27 nM, 5-HT1A Receptor:2.3 nM, σ1 receptor:47 nM, σ2 receptor:56 mM |
| In vitro | OPC-14523 inhibits the in vitro reuptake of 3H-5-HT (IC50 = 27 nM), but exhibits very weak inhibition activity against the reuptake of 3H-NE and 3H-DA. OPC-14523 does not inhibit activity at the A or B receptors or muscarinic receptors. |
| In vivo | In Wistar rats (140-245 g), OPC-14523 hydrochloride (0.3-100 mg/kg; orally; daily for 0, 2, 4, 7 days) reduces immobility time in the depression experiment[1]. |
| Synonyms | VPI 013 hydrochloride |
| Molecular Weight | 450.4 |
| Formula | C23H29Cl2N3O2 |
| Cas No. | 145969-31-9 |
| Smiles | Cl.COc1cccc2N(CCCN3CCN(CC3)c3cccc(Cl)c3)C(=O)CCc12 |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 60 mg/mL (133.21 mM), Sonification is recommended. H2O: 3 mg/mL (6.66 mM), Sonification is recommended. | ||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL (5.55 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.